Yvonne Lopez
Family · Lubbock, TXNPI 1598244865
Payments from drug & device makers
Across 182 payments — averaging $28.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$1K
- Otsuka America Pharmaceutical, Inc.$762
- Bayer$465
- OPKO Pharmaceuticals, LLC$407
- Amgen$339
- Akebia Therapeutics Inc$313
- plus $2K from 19 others
What the payments were for
- Travel & lodging$1,03520%
- Food & beverage$4,12879%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 12 | $1,421 |
| Otsuka America Pharmaceutical, Inc. | 36 | $762 |
| Bayer | 26 | $465 |
| OPKO Pharmaceuticals, LLC | 19 | $407 |
| Amgen(2 entities) | 13 | $339 |
| Akebia Therapeutics Inc | 14 | $313 |
| AstraZeneca(2 entities) | 8 | $266 |
| Mallinckrodt Hospital Products Inc. | 8 | $213 |
| Novartis | 1 | $134 |
| Travere Therapeutics, Inc. | 6 | $111 |
| Medtronic | 1 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $97 |
| Boehringer Ingelheim | 6 | $97 |
| Fresenius USA Marketing, Inc. | 6 | $96 |
| Novo Nordisk | 4 | $77 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Vifor Pharma, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $42 |
| Amicus Therapeutics, Inc. | 2 | $36 |
| Atricure, Inc. | 1 | $34 |
| Ardelyx, Inc. | 2 | $32 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Sanofi | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Chronic$1,156
- Fabhalta$134
- JYNARQUE$123
- ULTOMIRIS$123
- SYMPLICITY G3$110
How this compares
$5,251 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Midodrine Hcl | 14 | $838 |
| Losartan Potassium | 17 | $101 |
| Doxycycline Hyclate | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other family in Lubbock
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.